Kupffer Phase Radiomics Signature in Sonazoid-Enhanced Ultrasound is an Independent and Effective Predictor of the Pathologic Grade of Hepatocellular Carcinoma

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr class="thead"><td class="align_left">Radiomic score</td><td class="align_center">AUC</td><td class="align_center">Accuracy</td><td class="align_center">Sensitivity</td><td class="align_center">Specificity</td></tr><tr><td class="thead-hr" colspan="5"><hr/></td></tr><tr><td class="align_left">grayRS</td><td class="align_center">0.555 (0.368, 0.733)</td><td class="align_center">66.2% (55.9%, 75.0%)</td><td class="align_center">46.7% (23.8%, 66.7%)</td><td class="align_center">71.7% (60.4%, 81.5%)</td></tr><tr><td class="align_left">APRS</td><td class="align_center">0.349 (0.170, 0.539)</td><td class="align_center">79.4% (72.1%, 86.8%)</td><td class="align_center">13.3% (0.00%, 30.0%)</td><td class="align_center">98.1% (94.4%, 100.0%)</td></tr><tr><td class="align_left">KPRS</td><td class="align_center">0.937 (0.821, 1.000)</td><td class="align_center">97.1% (92.6%, 100.0%)</td><td class="align_center">93.3% (80.0%, 100.0%)</td><td class="align_center">98.1% (94.6%, 100.0%)</td></tr><tr class="table-tr"><td colspan="5"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>grayRS : grayscale radiomic score; APRS : arterial phase radiomic score; KPRS : Kupffer phase radiomic score.<br/></div></td></tr></table>

<div>Prediction performance on p-HCC versus w/m-HCC.</div>

Journal of Oncology

tab1

Table 1

Table 1: Kupffer Phase Radiomics Signature in Sonazoid-Enhanced Ultrasound is an Independent and Effective Predictor of the Pathologic Grade of Hepatocellular Carcinoma 

Table 1 | Kupffer Phase Radiomics Signature in Sonazoid-Enhanced Ultrasound is an Independent and Effective Predictor of the Pathologic Grade of Hepatocellular Carcinoma 